Table 5.
Women diagnosed before pregnancy (n = 15) | Women diagnosed during pregnancy or at delivery (n = 26) | |||
---|---|---|---|---|
n | % | n | % | |
Viral load nearest conceptionb | (n = 14)a | (n = 26) | ||
< 1000 | 3 | 21 | 2 | 8 |
1000–99 999 | 10 | 71 | 16 | 61 |
≥ 100 000 | 1 | 7 | 8 | 31 |
Viral load nearest deliveryb | (n = 14)a | (n = 25) | ||
< 50 | 7 | 50 | 3 | 12 |
50–999 | 3 | 21 | 9 | 36 |
1000–99 999 | 3 | 21 | 10 | 40 |
≥ 100 000 | 1 | 8 | 3 | 12 |
CD4 count nearest conceptionc | (n = 13)a | (n = 26) | ||
< 250 | 4 | 31 | 10 | 39 |
250–349 | 5 | 38 | 6 | 23 |
350–499 | 1 | 8 | 6 | 23 |
≥ 500 | 3 | 23 | 4 | 15 |
On ART at conception | (n = 14)a | |||
Yes | 6 | 43 | – | – |
No | 8 | 57 | – | – |
One case of missing information on test results and ART at conception as respondent could not access case notes.
ART, antiretroviral therapy.
copies/mL
cells/μL